Actively Recruiting
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-06-12
130
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.
CONDITIONS
Official Title
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with conditions related to chronic lower back pain
- Age above 18 years
- Not pregnant
You will not qualify if you...
- Cancer pain
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mount Sinai Pain management centers
New York, New York, United States, 10029
Actively Recruiting
Research Team
C
Chinwe Nwaneshiudu, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here